Detailed Information on Publication Record
2023
Microsatellite instability in non-endometrioid ovarian epithelial tumors: a study of 400 cases comparing immunohistochemistry, PCR, and NGS based testing with mutation status of MMR genes
HÁJKOVÁ, Nikola, Michaela BÁRTŮ KENDALL, David CIBULA, Jana DROZENOVÁ, Pavel FABIAN et. al.Basic information
Original name
Microsatellite instability in non-endometrioid ovarian epithelial tumors: a study of 400 cases comparing immunohistochemistry, PCR, and NGS based testing with mutation status of MMR genes
Authors
HÁJKOVÁ, Nikola (203 Czech Republic), Michaela BÁRTŮ KENDALL (203 Czech Republic), David CIBULA (203 Czech Republic), Jana DROZENOVÁ (203 Czech Republic), Pavel FABIAN (203 Czech Republic), Oluwole FADARE, Filip FRÜHAUF (203 Czech Republic), Jitka HAUSNEROVÁ (203 Czech Republic, belonging to the institution), Jan HOJNÝ (203 Czech Republic), Eva KRKAVCOVÁ (203 Czech Republic), Jan LACO (203 Czech Republic), Sigurd F LAX, Radoslav MATĚJ (203 Czech Republic), Gábor MÉHES, Romana MICHÁLKOVÁ (203 Czech Republic), Kristýna NĚMEJCOVÁ (203 Czech Republic), Naveena SINGH, Simona STOLNICU (203 Czech Republic), Marián ŠVAJDLER (203 Czech Republic), Tomáš ZIMA (203 Czech Republic), Wilson Glenn MCCLUGGAGE, Ivana STRUŽINSKÁ (203 Czech Republic) and Pavel DUNDR (203 Czech Republic)
Edition
Translational research, NEW YORK, ELSEVIER SCIENCE INC, 2023, 1931-5244
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30109 Pathology
Country of publisher
United States of America
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 7.800 in 2022
RIV identification code
RIV/00216224:14110/23:00131347
Organization unit
Faculty of Medicine
UT WoS
001067763800001
Keywords in English
non-endometrioid ovarian epithelial tumors; microsatellite instability
Tags
International impact, Reviewed
Změněno: 12/1/2024 13:39, Mgr. Tereza Miškechová
Abstract
V originále
Testing of microsatellite instability is not only used as a triage for possible Lynch syndrome, but also to predict immunotherapy treatment response. The aim of this study was to assess the frequency of mismatch repair deficiency (MMR-D)/microsatellite instability (MSI) in 400 cases of non-endometrioid ovarian tumors (high-grade serous, low-grade serous, mucinous and clear cell), to compare different methodological approaches of testing, and to assess the optimal approach for next generation sequencing (NGS) MSI testing. For all tumors, we evaluated immunohistochemical (IHC) expression of MMR proteins and assessed microsatellite markers by PCR-based method. Except for high-grade serous carcinoma, we correlated the findings of IHC and PCR with NGS-based MSI testing. We compared the results with somatic and germline mutation in MMR genes. Among the whole cohort, seven MMR-D cases, all clear cell carcinomas (CCC), were found. On PCR analysis, 6 cases were MSI-high and one was MSS. In all cases, mutation of an MMR gene was found; in 2 cases, the mutation was germline (Lynch syndrome). An additional 5 cases with a mutation in MMR gene(s) with MSS status and without MMR-D were identified. We further utilized sequence capture NGS for MSI testing. Employing 53 microsatellite loci provided high sensitivity and specificity. Our study shows that MSI occurs in 7% of CCC while it is rare or absent in other nonendometrioid ovarian neoplasms. Lynch syndrome was present in 2% of patients with CCC. However, some cases with MSH6 mutation can evade all testing methods, including IHC, PCR, and NGS-MSI.
Links
90233, large research infrastructures |
|